Immunologic targeting of native and mutated ESR1 receptor for treatment of hormone receptor expressing metastatic breast cancer. This is an ASCO Meeting Abstract from the 2025 ASCO Annual Meeting I.
Researchers at The University of Texas MD Anderson Cancer Center have identified a key enzyme—RNase H2—that helps ...
“Despite progress in treating breast cancer during the past 30 years, we still lack curative therapies for metastatic disease. EVOLVE takes a different approach to clinical research by using real-time ...
Health care is undergoing an important and well-needed shift from a one-size-fits-all approach to more personalized, precise, patient-focused care. A similar approach needs to be implemented at scale ...
Evaluating the utility of routine survivorship exams in breast cancer: Modality of detection of recurrence in a prospective cohort study. This is an ASCO Meeting Abstract from the 2024 ASCO Annual ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results